Stocks
STIMCELL ENERGETICS INC.STME
OQBHealthcareBiotechnology$0.15
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing cell-based therapies for degenerative diseases, with a focus on stem cell-derived treatments for orthopedic and neurological conditions. Investors track STME for its early-stage pipeline and potential in regenerative medicine, though it has yet to generate revenue.
52W Range: $0.15-$0.48
Congressional Interest in STIMCELL ENERGETICS INC. (STME)
No congressional trades have been disclosed for STIMCELL ENERGETICS INC. (STME) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading STME?
No congressional trades found for this stock.